{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:24:51Z","timestamp":1790807091230,"version":"4.1.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Visva-Bharati University"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.heliyon.2019.e02624","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T08:30:46Z","timestamp":1573720246000},"page":"e02624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies"],"prefix":"10.1016","volume":"5","author":[{"given":"Koustav","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyanki","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabanita Roy","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipa","family":"Mal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tathagata","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003186","article-title":"Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein \u0394Np73\u03b1","volume":"9","author":"Accardi","year":"2013","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/JVI.79.3.1789-1802.2005","article-title":"The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility","volume":"79","author":"Allen","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/cdd.2010.91","article-title":"p53 directly transactivates \u0394133p53\u03b1, regulating cell fate outcome in response to DNA damage","volume":"18","author":"Aoubala","year":"2010","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.heliyon.2019.e02624_bib4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1158\/1078-0432.CCR-07-1422","article-title":"Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin","volume":"14","author":"Avery-Kiejda","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.heliyon.2019.e02624_bib5","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1073\/pnas.062491899","article-title":"Induction of p57KIP2 expression by p73","volume":"99","author":"Balint","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"15","key":"10.1016\/j.heliyon.2019.e02624_bib6","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1158\/0008-5472.CAN-06-2020","article-title":"Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis","volume":"66","author":"Barbieri","year":"2006","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib7","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1128\/JVI.72.10.8105-8114.1998","article-title":"Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-Tetradecanoylphorbol-13-Acetate-Induced phosphorylation","volume":"72","author":"Baumann","year":"1998","journal-title":"J.\u00a0Virol."},{"issue":"15","key":"10.1016\/j.heliyon.2019.e02624_bib8","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1093\/nar\/gku697","article-title":"Epstein\u2013Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1","volume":"42","author":"Bazot","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib9","first-page":"889","article-title":"Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers","volume":"29","author":"Becker","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"42","key":"10.1016\/j.heliyon.2019.e02624_bib10","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.0907994106","article-title":"Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis","volume":"106","author":"Bieging","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejca.2006.10.019","article-title":"Expression of p53 isoforms in squamous cell carcinoma of the head and neck","volume":"43","author":"Boldrup","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"18","key":"10.1016\/j.heliyon.2019.e02624_bib12","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1101\/gad.1339905","article-title":"p53 isoforms can regulate p53 transcriptional activity","volume":"19","author":"Bourdon","year":"2005","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002418","article-title":"Epstein-barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis","volume":"7","author":"Cai","year":"2011","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.heliyon.2019.e02624_bib14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/humu.22523","article-title":"How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors","volume":"35","author":"Candi","year":"2014","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3324\/haematol.2010.031161","article-title":"Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph","volume":"96","author":"Casabonne","year":"2011","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.heliyon.2019.e02624_bib16","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1093\/nar\/28.20.3918","article-title":"Activation of the BRLF1 promoter and lytic cycle of Epstein\u2013Barr virus by histone acetylation","volume":"28","author":"Chang","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/viro.1998.9431","article-title":"Levels of p53 in Epstein\u2013Barr virus-infected cells determine cell fate: apoptosis, cell cycle arrest at the G1\/S boundary without apoptosis, cell cycle arrest at the G2\/M boundary without apoptosis, or unrestricted proliferation","volume":"251","author":"Chen","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.heliyon.2019.e02624_bib18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.onc.1204149","article-title":"p73 is transcriptionally regulated by DNA damage, p53, and p73","volume":"20","author":"Chen","year":"2001","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4161\/cc.8.1.7411","article-title":"The Epstein-Barr virus replication and transcription activator, Rta\/BRLF1, induces cellular senescence in epithelial cells","volume":"8","author":"Chen","year":"2009","journal-title":"Cell Cycle"},{"issue":"14","key":"10.1016\/j.heliyon.2019.e02624_bib20","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1128\/JVI.03159-12","article-title":"Epstein-barr virus-encoded MicroRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE","volume":"87","author":"Choi","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"23","key":"10.1016\/j.heliyon.2019.e02624_bib21","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","article-title":"Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation","volume":"86","author":"Cohen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.urology.2007.04.030","article-title":"p63 gene expression study and early bladder carcinogenesis","volume":"70","author":"Comp\u00e9rat","year":"2007","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.heliyon.2019.e02624_bib23","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1158\/0008-5472.CAN-03-1060","article-title":"Transdominant \u0394TAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo","volume":"64","author":"Concin","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2019.e02624_bib24","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/sj.onc.1203656","article-title":"High level expression of \u0394N-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)","volume":"19","author":"Crook","year":"2000","journal-title":"Oncogene"},{"issue":"18","key":"10.1016\/j.heliyon.2019.e02624_bib25","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1158\/0008-5472.CAN-14-3363","article-title":"\u0394Np63\u03b1 promotes breast cancer cell motility through the selective activation of components of the epithelial-to-mesenchymal transition program","volume":"75","author":"Dang","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/MCB.19.2.1438","article-title":"p73 function is inhibited by tumor-derived p53 mutants in mammalian cells","volume":"19","author":"Di Como","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2005.02.2350","article-title":"\u0394TAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1","volume":"24","author":"Dom\u00ednguez","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood.V96.2.625.014k27_625_634","article-title":"Stable expression of Epstein-Barr virus BZLF-1\u2013encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells","volume":"96","author":"Dreyfus","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.heliyon.2019.e02624_bib29","first-page":"1575","article-title":"Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMPI","volume":"8","author":"F Hu","year":"1993","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib30","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.00170-09","article-title":"The Epstein-Barr virus alkaline Exonuclease BGLF5 serves pleiotropic functions in virus replication","volume":"83","author":"Feederle","year":"2009","journal-title":"J.\u00a0Virol."},{"issue":"21","key":"10.1016\/j.heliyon.2019.e02624_bib31","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1128\/JVI.00525-09","article-title":"The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production","volume":"83","author":"Feederle","year":"2009","journal-title":"J.\u00a0Virol."},{"issue":"19","key":"10.1016\/j.heliyon.2019.e02624_bib32","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1128\/JVI.05100-11","article-title":"The members of an Epstein-Barr virus MicroRNA cluster cooperate to transform B lymphocytes","volume":"85","author":"Feederle","year":"2011","journal-title":"J.\u00a0Virol."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2013-07-517649","article-title":"Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma","volume":"123","author":"Fish","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib34","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1261\/rna.2339606","article-title":"Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22","volume":"12","author":"Fok","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.heliyon.2019.e02624_bib35","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/onc.2010.175","article-title":"Epstein-Barr virus latent membrane protein-2A-induced \u0394Np63\u03b1 expression is associated with impaired epithelial-cell differentiation","volume":"29","author":"Fotheringham","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2019.e02624_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/47266","article-title":"p53 inhibition by the LANA protein of KSHV protects against cell death","volume":"402","author":"Friborg","year":"1999","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib37","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1128\/jvi.70.12.8653-8659.1996","article-title":"Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene","volume":"70","author":"Fries","year":"1996","journal-title":"J.\u00a0Virol."},{"issue":"9","key":"10.1016\/j.heliyon.2019.e02624_bib38","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ncb1928","article-title":"p53 isoforms, \u0394133p53 and p53\u03b2, are endogenous regulators of replicative cellular senescence","volume":"11","author":"Fujita","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2019.e02624_bib39","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/JVI.03714-13","article-title":"Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation","volume":"88","author":"Fukuda","year":"2014","journal-title":"J.\u00a0Virol."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib40","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/MCB.21.5.1874-1887.2001","article-title":"A\u00a0subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain","volume":"21","author":"Gaiddon","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib41","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/sj.emboj.7600708","article-title":"TAp63\u03b1 induces apoptosis by activating signaling via death receptors and mitochondria","volume":"24","author":"Gressner","year":"2005","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib42","first-page":"31","article-title":"The expression of p63 gene in human non-small cell lung cancer","volume":"7","author":"Guo","year":"2004","journal-title":"Chin. J. Lung Canc."},{"key":"10.1016\/j.heliyon.2019.e02624_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-4-23","article-title":"The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection","volume":"4","author":"Guo","year":"2006","journal-title":"J.\u00a0Transl. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/ncb1988","article-title":"TAp63 induces senescence and suppresses tumorigenesis in vivo","volume":"11","author":"Guo","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/ncb1988","article-title":"TAp63 induces senescence and suppresses tumorigenesis in vivo","volume":"11","author":"Guo","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2019.e02624_bib46","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1128\/JVI.01856-10","article-title":"The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner","volume":"85","author":"Hagemeier","year":"2011","journal-title":"J.\u00a0Virol."},{"issue":"8","key":"10.1016\/j.heliyon.2019.e02624_bib47","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.4049\/jimmunol.1200312","article-title":"Cutting edge: mir-223 and EBV mir-BART15 regulate the NLRP3 inflammasome and IL-1\u03b2 production","volume":"189","author":"Haneklaus","year":"2012","journal-title":"J.\u00a0Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2019.e02624_bib48","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1128\/jvi.71.9.6611-6618.1997","article-title":"Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation","volume":"71","author":"Harada","year":"1997","journal-title":"J.\u00a0Virol."},{"issue":"9","key":"10.1016\/j.heliyon.2019.e02624_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003638","article-title":"Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9","volume":"9","author":"Harth-Hertle","year":"2013","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/jvi.62.4.1101-1107.1988","article-title":"Identification of the Epstein-Barr virus gp85 gene","volume":"62","author":"Heineman","year":"1988","journal-title":"J.\u00a0Virol."},{"issue":"6","key":"10.1016\/j.heliyon.2019.e02624_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/rmv.1758","article-title":"BamHI-A rightward frame 1, an Epstein\u2013Barr virus-encoded oncogene and immune modulator","volume":"23","author":"Hoebe","year":"2013","journal-title":"Rev. Med. Virol."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/cancers10030076","article-title":"Epstein\u2013barr virus gene BARF1 expression is regulated by the epithelial differentiation factor \u0394Np63\u03b1 in undifferentiated nasopharyngeal carcinoma","volume":"10","author":"Hoebe","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2019.e02624_bib53","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/onc.2009.482","article-title":"Alternative splicing of p53 and p73: the novel p53 splice variant p53\u03b4 is an independent prognostic marker in ovarian cancer","volume":"29","author":"Hofstetter","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib54","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/JVI.79.2.745-755.2005","article-title":"The Epstein-Barr virus protein BMRF1 activates gastrin transcription","volume":"79","author":"Holley-Guthrie","year":"2005","journal-title":"J.\u00a0Virol."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib55","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000150528","article-title":"The Epstein Barr virus genome encodes deoxythymidine kinase activity in a nested internal open reading frame","volume":"39","author":"Holton","year":"1996","journal-title":"Intervirology"},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib56","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1128\/JVI.78.10.4983-4992.2004","article-title":"The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1","volume":"78","author":"Hong","year":"2004","journal-title":"J.\u00a0Virol."},{"issue":"19","key":"10.1016\/j.heliyon.2019.e02624_bib57","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.1128\/JVI.01014-09","article-title":"Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribosomal protein L22 binding","volume":"83","author":"Houmani","year":"2009","journal-title":"J.\u00a0Virol."},{"issue":"20","key":"10.1016\/j.heliyon.2019.e02624_bib58","doi-asserted-by":"crossref","first-page":"E3964","DOI":"10.1073\/pnas.1617816114","article-title":"\u0394Np63\u03b1 is a common inhibitory target in oncogenic PI3K\/Ras\/Her2-induced cell motility and tumor metastasis","volume":"114","author":"Hu","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbrc.2005.02.028","article-title":"p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription","volume":"329","author":"Innocente","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib60","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/cancers6031615","article-title":"Epstein-barr virus-encoded RNAs: key molecules in viral pathogenesis","volume":"6","author":"Iwakiri","year":"2014","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib61","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.20081761","article-title":"Epstein-Barr virus (EBV)\u2013encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3","volume":"206","author":"Iwakiri","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib62","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1073\/pnas.94.4.1447","article-title":"The Epstein\u2013Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte\u2009growth\u2009transformation","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"21","key":"10.1016\/j.heliyon.2019.e02624_bib63","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1128\/JVI.74.21.10142-10152.2000","article-title":"Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350\/220) demonstrates the existence of additional viral ligands","volume":"74","author":"Janz","year":"2000","journal-title":"J.\u00a0Virol."},{"issue":"46","key":"10.1016\/j.heliyon.2019.e02624_bib64","doi-asserted-by":"crossref","first-page":"16286","DOI":"10.1073\/pnas.0407320101","article-title":"Proteins of purified Epstein-Barr virus","volume":"101","author":"Johannsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2019.e02624_bib65","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1038\/sj.onc.1210941","article-title":"p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis","volume":"27","author":"Johnson","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2019.e02624_bib66","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1038\/emm.2014.84","article-title":"Epstein\u2013Barr virus latent genes","volume":"47","author":"Kang","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib67","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0006-291X(02)02261-1","article-title":"Epstein\u2013Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells","volume":"297","author":"Kawanishi","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib68","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.stem.2010.12.009","article-title":"\u0394Np63\u03b1 is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis","volume":"8","author":"Keyes","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"15","key":"10.1016\/j.heliyon.2019.e02624_bib69","first-page":"5501","article-title":"Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder","volume":"9","author":"Koga","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib70","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","article-title":"Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line akata","volume":"73","author":"Komano","year":"1999","journal-title":"J.\u00a0Virol."},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib71","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1128\/JVI.00120-07","article-title":"Epstein-barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II","volume":"81","author":"Lee","year":"2007","journal-title":"J.\u00a0Virol."},{"issue":"23","key":"10.1016\/j.heliyon.2019.e02624_bib72","doi-asserted-by":"crossref","first-page":"11913","DOI":"10.1128\/JVI.01100-08","article-title":"Epstein-barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production","volume":"82","author":"Lee","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib74","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/JVI.76.1.232-242.2002","article-title":"Epstein-barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2","volume":"76","author":"Lin","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib75","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/sj.onc.1208319","article-title":"Epstein\u2013Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity","volume":"24","author":"Liu","year":"2004","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib76","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1158\/1078-0432.CCR-05-2573","article-title":"Expression of \u0394Np73 and TAp73\u03b1 independently associated with radiosensitivities and prognoses in cervical squamous cell carcinoma","volume":"12","author":"Liu","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib77","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/JTO.0b013e31820b86b0","article-title":"p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue","volume":"6","author":"Lo Iacono","year":"2011","journal-title":"J.\u00a0Thorac. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib78","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/rmed.2001.1152","article-title":"Epstein\u2013Barr virus and wild p53 in idiopathic pulmonary fibrosis","volume":"95","author":"Lok","year":"2001","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2019.e02624_bib79","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/mc.20835","article-title":"Effects of \u0394Np73\u03b2 on cisplatin treatment in colon cancer cells","volume":"51","author":"L\u00f6\u00f6f","year":"2012","journal-title":"Mol. Carcinog."},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib80","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib81","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus","volume":"106","author":"Mancao","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib82","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1128\/jvi.65.12.6826-6837.1991","article-title":"The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation","volume":"65","author":"Mannick","year":"1991","journal-title":"J.\u00a0Virol."},{"issue":"21","key":"10.1016\/j.heliyon.2019.e02624_bib83","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1016\/j.febslet.2010.10.005","article-title":"\u0394160p53 is a novel N-terminal p53 isoform encoded by \u0394133p53 transcript","volume":"584","author":"Marcel","year":"2010","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/annonc\/mdm519","article-title":"\u0394Np63 expression is associated with poor survival in ovarian cancer","volume":"19","author":"Marchini","year":"2008","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib85","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1073\/pnas.1019599108","article-title":"Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16(INK4A) and p14(ARF) expression","volume":"108","author":"Maruo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"16","key":"10.1016\/j.heliyon.2019.e02624_bib86","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1128\/JVI.01581-13","article-title":"Roles of p53 in herpes simplex virus 1 replication","volume":"87","author":"Maruzuru","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"21","key":"10.1016\/j.heliyon.2019.e02624_bib87","first-page":"7113","article-title":"Significance of p63 amplification and overexpression in lung cancer development and prognosis","volume":"63","author":"Massion","year":"2003","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib88","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.tibs.2003.10.004","article-title":"Functional regulation of p73 and p63: development and cancer","volume":"28","author":"Melino","year":"2003","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib89","article-title":"TAp63alpha induced apoptosis inhibited by Kaposi's sarcoma herpesvirus latency nuclear antigen","volume":"6","author":"Mohanty","year":"2015","journal-title":"J.\u00a0Carcinog. Mutagen."},{"issue":"7","key":"10.1016\/j.heliyon.2019.e02624_bib90","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1541-7786.371.2.7","article-title":"p63 and p73: roles in development and tumor formation","volume":"2","author":"Moll","year":"2004","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib91","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/JVI.79.4.2375-2382.2005","article-title":"Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of \u03b2-catenin signaling","volume":"79","author":"Morrison","year":"2005","journal-title":"J.\u00a0Virol."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib92","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family","volume":"80","author":"Mosialos","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2019.e02624_bib93","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.cdd.4401914","article-title":"p53\/p63\/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress","volume":"13","author":"Murray-Zmijewski","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.heliyon.2019.e02624_bib94","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1038\/srep11767","article-title":"A\u00a0herpesvirus specific motif of Epstein-Barr virus DNA polymerase is required for the efficient lytic genome synthesis","volume":"5","author":"Narita","year":"2015","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib95","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1128\/JVI.80.10.5078-5081.2006","article-title":"The Epstein-Barr virus BMRF1 gene is essential for lytic virus replication","volume":"80","author":"Neuhierl","year":"2006","journal-title":"J.\u00a0Virol."},{"issue":"47","key":"10.1016\/j.heliyon.2019.e02624_bib96","doi-asserted-by":"crossref","first-page":"18952","DOI":"10.1073\/pnas.1221172110","article-title":"TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor","volume":"110","author":"Niklison-Chirou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib97","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1054\/bjoc.2001.2138","article-title":"p73 is over-expressed in vulval cancer principally as the Delta 2 isoform","volume":"85","author":"O'Nions","year":"2001","journal-title":"Br. J. Canc."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib98","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib99","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-17-47","article-title":"Involvement of p63 in the herpes simplex virus-1-induced demise of corneal cells","volume":"17","author":"Orosz","year":"2010","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib100","first-page":"3370","article-title":"Frequent alteration of p63 expression in human primary bladder carcinomas","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.heliyon.2019.e02624_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000492","article-title":"Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim","volume":"5","author":"Paschos","year":"2009","journal-title":"PLoS Pathog."},{"issue":"285","key":"10.1016\/j.heliyon.2019.e02624_bib102","article-title":"p53 family and cellular stress responses in cancer","volume":"4","author":"Pflaum","year":"2014","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib103","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood-2004-03-0799","article-title":"Chemokine receptor expression in EBV-associated lymphoproliferation in hu\/SCID mice: implications for CXCL12\/CXCR4 axis in lymphoma generation","volume":"105","author":"Piovan","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.heliyon.2019.e02624_bib104","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1128\/JVI.72.10.7978-7984.1998","article-title":"The Epstein-Barr virus rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes","volume":"72","author":"Ragoczy","year":"1998","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2407-14-559","article-title":"\u0394Np63\u03b1 enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2","volume":"14","author":"Ram Kumar","year":"2014","journal-title":"BMC Canc."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib106","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/JVI.01723-07","article-title":"Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection","volume":"82","author":"Rechsteiner","year":"2008","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0166-0934(95)01970-7","article-title":"Expression and purification of an Epstein-Barr virus encoded 23-kDa protein and characterization of its immunological properties","volume":"57","author":"Reischl","year":"1996","journal-title":"J.\u00a0Virol Methods"},{"issue":"8","key":"10.1016\/j.heliyon.2019.e02624_bib108","first-page":"1822","article-title":"A\u00a0putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components","volume":"5","author":"Reisman","year":"1985","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0100-879X2004000100013","article-title":"Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies?","volume":"37","author":"Ribeiro-Silva","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2005.12.013","article-title":"p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis","volume":"9","author":"Rocco","year":"2006","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib111","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/JVI.01302-06","article-title":"Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity","volume":"81","author":"Rovedo","year":"2007","journal-title":"J.\u00a0Virol."},{"issue":"9","key":"10.1016\/j.heliyon.2019.e02624_bib112","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1073\/pnas.0611128104","article-title":"Host shutoff during productive Epstein\u2013Barr virus infection is mediated by BGLF5 and may contribute to immune evasion","volume":"104","author":"Rowe","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib113","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.75.13.6033-6041.2001","article-title":"Epstein-barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA","volume":"75","author":"Ruvolo","year":"2001","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib114","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-1702(01)00376-8","article-title":"Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients","volume":"81","author":"Sacaze","year":"2001","journal-title":"Virus Res."},{"issue":"20","key":"10.1016\/j.heliyon.2019.e02624_bib115","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.febslet.2011.08.007","article-title":"Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses","volume":"585","author":"Saha","year":"2011","journal-title":"FEBS Letters"},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib116","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1128\/JVI.02279-10","article-title":"EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5","volume":"85","author":"Saha","year":"2011","journal-title":"J.\u00a0Virol."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001275","article-title":"Epstein-barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1","volume":"7","author":"Saha","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2019.e02624_bib118","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.virol.2013.10.023","article-title":"Epstein\u2013Barr virus nuclear antigen 3C interact with p73: interplay between a viral oncoprotein and cellular tumor suppressor","volume":"448","author":"Sahu","year":"2014","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.heliyon.2019.e02624_bib119","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/sj.emboj.7601314","article-title":"EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN","volume":"25","author":"Samanta","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2019.e02624_bib120","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/onc.2012.385","article-title":"Recruitment of the tumour suppressor protein p73 by Kaposi\u2019s Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells","volume":"32","author":"Santag","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2005.02.029","article-title":"Structure of the p53 binding domain of HAUSP\/USP7 Bound to Epstein-Barr nuclear antigen 1","volume":"18","author":"Saridakis","year":"2005","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib122","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4161\/cc.9.4.10675","article-title":"Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication","volume":"9","author":"Sato","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.heliyon.2019.e02624_bib123","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/sj.onc.1210898","article-title":"Wild-type p53 and p73 negatively regulate expression of proliferation related genes","volume":"27","author":"Scian","year":"2007","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.heliyon.2019.e02624_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001063","article-title":"Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells","volume":"6","author":"Seto","year":"2010","journal-title":"PLoS Pathog."},{"issue":"15","key":"10.1016\/j.heliyon.2019.e02624_bib125","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.00108-09","article-title":"Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification","volume":"83","author":"Shannon-Lowe","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib126","first-page":"2309","article-title":"Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma","volume":"24","author":"Shao","year":"2004","journal-title":"Anticancer Res."},{"issue":"14","key":"10.1016\/j.heliyon.2019.e02624_bib127","doi-asserted-by":"crossref","first-page":"18116","DOI":"10.18632\/oncotarget.7502","article-title":"An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53\/Mdm2 and Cyclin D1\/CDK6 which results in apoptosis and reduced cell proliferation","volume":"7","author":"Shukla","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.heliyon.2019.e02624_bib128","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1128\/JVI.00013-12","article-title":"Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection","volume":"86","author":"Sivachandran","year":"2012","journal-title":"J.\u00a0Virol."},{"issue":"7","key":"10.1016\/j.heliyon.2019.e02624_bib129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-017-2701-z","article-title":"Master regulatory role of p63 in epidermal development and disease","volume":"75","author":"Soares","year":"2018","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"issue":"8","key":"10.1016\/j.heliyon.2019.e02624_bib130","first-page":"921","article-title":"Expression of p53 isoforms in renal cell carcinoma","volume":"122","author":"Song","year":"2009","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tcb.2009.10.002","article-title":"Transcription-independent p53 apoptosis: an alternative route to death","volume":"20","author":"Speidel","year":"2010","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib132","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1158\/1078-0432.CCR-0153-03","article-title":"Quantitative TP73 transcript analysis in hepatocellular carcinomas","volume":"10","author":"Stiewe","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2019.e02624_bib133","doi-asserted-by":"crossref","first-page":"18817","DOI":"10.1074\/jbc.M201405200","article-title":"Physical interaction with human tumor-derived p53 mutants inhibits p63 activities","volume":"277","author":"Strano","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib134","first-page":"410","article-title":"A\u00a0vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus","volume":"5","author":"Sugden","year":"1985","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/DAD.0b013e31812f52bd","article-title":"p63 in primary cutaneous carcinosarcoma","volume":"29","author":"Suh","year":"2007","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib136","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/cdd.2017.174","article-title":"Mechanisms of transcriptional regulation by p53","volume":"25","author":"Sullivan","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.heliyon.2019.e02624_bib137","first-page":"57","article-title":"Uncovering the role of p53 splice variants in human malignancy: a clinical perspective","volume":"7","author":"Surget","year":"2014","journal-title":"OncoTargets Ther."},{"issue":"Pt 9","key":"10.1016\/j.heliyon.2019.e02624_bib138","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1099\/vir.0.021444-0","article-title":"Epstein\u2013Barr virus LMP2A imposes sensitivity to apoptosis","volume":"91","author":"Swanson-Mungerson","year":"2010","journal-title":"J.\u00a0Gen. Virol."},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib139","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1128\/JVI.75.13.6228-6234.2001","article-title":"Epstein-barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation","volume":"75","author":"Swenson","year":"2001","journal-title":"J.\u00a0Virol."},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib140","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1073\/pnas.90.12.5455","article-title":"EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins","volume":"90","author":"Szekely","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib141","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.2741\/2000","article-title":"Epstein-Barr virus (EBV) and its associated human cancers - genetics, epigenetics, pathobiology and novel therapeutics","volume":"11","author":"Tao","year":"2006","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib142","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ijc.22275","article-title":"p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma","volume":"120","author":"Tetsuo","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib143","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib144","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/bbrc.2000.3627","article-title":"Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia","volume":"277","author":"Tschan","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib145","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/viro.1996.0432","article-title":"Epstein\u2013barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase","volume":"222","author":"Tsurumi","year":"1996","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib146","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijc.11552","article-title":"Alterations of \u0394TA-p73 splice transcripts during melanoma development and progression","volume":"108","author":"Tve","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.heliyon.2019.e02624_bib147","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1158\/1078-0432.CCR-04-0290","article-title":"Expression of \u0394Np73 predicts poor prognosis in lung cancer","volume":"10","author":"Uramoto","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.heliyon.2019.e02624_bib148","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1128\/jvi.67.7.3908-3916.1993","article-title":"Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins","volume":"67","author":"van Grunsven","year":"1993","journal-title":"J.\u00a0Virol."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib149","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbabio.2008.10.005","article-title":"The mitochondrial p53 pathway","volume":"1787","author":"Vaseva","year":"2009","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/nar\/28.2.513","article-title":"p73 competes with p53 and attenuates its response in a human ovarian cancer cell line","volume":"28","author":"Vikhanskaya","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib151","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.jmb.2018.04.034","article-title":"p73 alternative splicing: exploring a biological role for the C-terminal isoforms","volume":"430","author":"Vikhreva","year":"2018","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib152","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1038\/onc.2010.319","article-title":"Characterization of \u0394Np73 expression and regulation in gastric and esophageal tumors","volume":"29","author":"Vilgelm","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib153","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1158\/1535-7163.MCT-09-0912","article-title":"Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors","volume":"9","author":"Vilgelm","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"14","key":"10.1016\/j.heliyon.2019.e02624_bib154","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1158\/0008-5472.CAN-06-0511","article-title":"p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"issue":"3, Part 2","key":"10.1016\/j.heliyon.2019.e02624_bib155","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","article-title":"An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells","volume":"43","author":"Wang","year":"1985","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.heliyon.2019.e02624_bib156","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1167\/iovs.05-0051","article-title":"Regulation of limbal keratinocyte proliferation and differentiation by TAp63 and \u0394Np63 transcription factors","volume":"46","author":"Wang","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"40","key":"10.1016\/j.heliyon.2019.e02624_bib157","doi-asserted-by":"crossref","first-page":"29152","DOI":"10.1074\/jbc.M703408200","article-title":"TAp73 is a downstream target of p53 in controlling the cellular defense against stress","author":"Wang","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"issue":"20","key":"10.1016\/j.heliyon.2019.e02624_bib158","doi-asserted-by":"crossref","first-page":"e00312","DOI":"10.1128\/JVI.00312-17","article-title":"Tumor suppressor p53 stimulates the expression of Epstein-Barr virus latent membrane protein 1","volume":"91","author":"Wang","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib159","first-page":"687359","article-title":"p53 family: role of protein isoforms in human cancer","volume":"2012","author":"Wei","year":"2012","journal-title":"J.\u00a0Nucleic Acids"},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02624_bib160","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI58092","article-title":"EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors","volume":"122","author":"White","year":"2012","journal-title":"J.\u00a0Clin. Investig."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib161","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-07-5126","article-title":"EBV MicroRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3","volume":"68","author":"Xia","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib162","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1006\/viro.1994.1578","article-title":"Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV","volume":"204","author":"Yalamanchili","year":"1994","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02624_bib163","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M","article-title":"Frequent gain of the p40\/p51\/p63 gene locus in primary head and neck squamous cell carcinoma","volume":"86","author":"Yamaguchi","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heliyon.2019.e02624_bib164","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/19539","article-title":"p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development","volume":"398","author":"Yang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2019.e02624_bib165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35003607","article-title":"p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours","volume":"404","author":"Yang","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2019.e02624_bib166","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/labinvest.2015.69","article-title":"Epstein\u2013Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage","volume":"95","author":"Yang","year":"2015","journal-title":"Lab. Investig."},{"issue":"12","key":"10.1016\/j.heliyon.2019.e02624_bib167","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1073\/pnas.81.12.3806","article-title":"A\u00a0cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells","volume":"81","author":"Yates","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2019.e02624_bib168","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","article-title":"Stable replication of plasmids derived from Epstein\u2013Barr virus in various mammalian cells","volume":"313","author":"Yates","year":"1985","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02624_bib169","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2009.03.027","article-title":"Epstein\u2013Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities","volume":"388","author":"Yi","year":"2009","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.heliyon.2019.e02624_bib170","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1099\/0022-1317-80-11-2879","article-title":"Assembly of the Epstein\u2013Barr virus BBLF4, BSLF1 and BBLF2\/3 proteins and their interactive properties","volume":"80","author":"Yokoyama","year":"1999","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.heliyon.2019.e02624_bib171","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/s41598-017-06413-7","article-title":"The Epstein-Barr virus BRRF1 gene is dispensable for viral replication in HEK293 cells and transformation","volume":"7","author":"Yoshida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2019.e02624_bib172","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein\u2013Barr virus and oncogenesis: from latent genes to tumours","volume":"22","author":"Young","year":"2003","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.heliyon.2019.e02624_bib173","first-page":"3257","article-title":"Overexpression of the wild type <em>p73<\/em> gene in breast cancer tissues and cell lines","volume":"59","author":"Zaika","year":"1999","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib174","first-page":"1929","article-title":"Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency","volume":"14","author":"Zhang","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02624_bib175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/viro.1997.8470","article-title":"The Epstein\u2013Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV oriLyt","volume":"230","author":"Zhang","year":"1997","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02624_bib176","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12250-017-3996-5","article-title":"An update: Epstein-Barr virus and immune evasion via microRNA regulation","volume":"32","author":"Zuo","year":"2017","journal-title":"Virol. Sin."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584401936284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584401936284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T08:57:15Z","timestamp":1738486635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584401936284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":176,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S240584401936284X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02624","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02624"}}